rifabutin
Showing 1 - 25 of 49
Helicobacter Pylori Infection Trial in Shanghai (Vonoprazan, Bismuth Potassium Citrate, Tetracycline)
Recruiting
- Helicobacter Pylori Infection
- Vonoprazan
- +5 more
-
Shanghai, Shanghai, ChinaRenji Hospital, School of Medicine, Shanghai Jiao Tong Universit
May 16, 2023
Tuberculosis Trial in Atlanta (Imatinib, Isoniazid, Rifabutin)
Recruiting
- Tuberculosis
- Imatinib
- +2 more
-
Atlanta, GeorgiaEmory University DAIDS TB Non-Network CRS
Jan 20, 2022
Bacterial Infections, Mycoses, HIV Trial in San Francisco, Seattle (Clarithromycin, Rifabutin, Sulfamethoxazole-Trimethoprim)
Completed
- Bacterial Infections
- +2 more
- Clarithromycin
- +4 more
-
San Francisco, California
- +1 more
Oct 27, 2021
Healthy, Male Trial in Daytona Beach (Zanubrutinib, Rifabutin)
Completed
- Healthy
- Male
- Zanubrutinib
- Rifabutin
-
Daytona Beach, FloridaCovance Clinical Research Unit
Aug 30, 2021
HIV Trial in United States (Indinavir sulfate, Rifabutin)
Completed
- HIV Infections
- Indinavir sulfate
- Rifabutin
-
Los Angeles, California
- +7 more
Oct 27, 2021
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
Helicobacter Infections, Resistance Bacterial, Gastritis H Pylori Trial (Rifabutin, Amoxicillin, Esomeprazole)
Not yet recruiting
- Helicobacter Infections
- +2 more
- Rifabutin
- +4 more
- (no location specified)
Mar 9, 2021
Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)
Completed
- Pulmonary Tuberculosis
- PA-824
- +5 more
-
Cape Town, South AfricaUniversity of Cape Town Lung Institute
May 18, 2022
HIV-1-infection Trial in Reutov (Elpida®, Rifampin, Rifabutin)
Completed
- HIV-1-infection
- Elpida®
- +6 more
-
Reutov, Moscow Region, Russian FederationCentral Clinical City Hospital
Jan 10, 2022
Mycobacterium Avium-intracellulare Infection, HIV Trial in Tanzania, United States (Clarithromycin, Rifabutin)
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
- Clarithromycin
- Rifabutin
-
Birmingham, Alabama
- +41 more
Oct 28, 2021
Infection, Human Immunodeficiency Virus, HIV Trial in Cambridge (Cabotegravir, Rifabutin)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- Cabotegravir
- Rifabutin
-
Cambridge, United KingdomGSK Investigational Site
Aug 27, 2020
Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)
Not yet recruiting
- Tuberculosis, Pulmonary
- Tuberculosis Infection
- Rifabutin
- +7 more
-
Denver, Colorado
- +14 more
Mar 2, 2023
HIV Infection, HIV-1 Infection, Mycobacterium Avium Complex (MAC) Trial in Ottawa (Rifabutin, Maraviroc)
Completed
- HIV Infection
- +2 more
- Rifabutin
- Maraviroc
-
Ottawa, Ontario, CanadaThe Ottawa Hospital -General Campus
Feb 25, 2020
HIV, Tuberculosis Trial in Bangkok, Nonthaburi (Lopinavir/r will be supplied by NHSO/GPO, Rifabutin)
Completed
- HIV
- Tuberculosis
- Lopinavir/r will be supplied by NHSO/GPO
- Rifabutin
-
Bangkok, Thailand
- +3 more
Feb 11, 2020
Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Ethambutol HCl, Clarithromycin, Clofazimine)
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
- Ethambutol hydrochloride
- +3 more
-
San Francisco, California
- +15 more
Oct 28, 2021
Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)
Recruiting
- Pulmonary Disease Due to Mycobacteria (Diagnosis)
- Amikacin
- +13 more
-
South Brisbane, Queensland, Australia
- +36 more
Sep 12, 2022
Mycobacterium Avium-intracellulare Infection, HIV Trial in Tanzania, United States (Indinavir sulfate, Ritonavir, Ethambutol
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
- Indinavir sulfate
- +4 more
-
Birmingham, Alabama
- +33 more
Oct 28, 2021
Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Trial in Japan (Bedaquiline, Clarithromycin, Ethambutol)
Recruiting
- Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
- Bedaquiline
- +4 more
-
Aichi, Japan
- +42 more
Jan 17, 2023
Safety And Efficacy Of Rifabutin In HIV Patients
Completed
- Non-tuberculous Mycobacterial Diseases
- +2 more
- rifabutin
- (no location specified)
Jun 13, 2019
Rifabutin In Patients For Non-HIV Patients
Completed
- Tuberculosis
- Non-tuberculous Mycobacterial Diseases (Including MAC Disease)
- rifabutin
- (no location specified)
Nov 12, 2018
Tuberculosis, Pulmonary, AIDS Trial in Shanghai (Rifampicin, Rifabutin)
Unknown status
- Tuberculosis, Pulmonary
- AIDS
- Rifampicin
- Rifabutin
-
Shanghai, Shanghai, ChinaShanghai Public Health Clinical Center
Apr 23, 2018
HIV Infection, Tuberculosis Trial in Worldwide (Standard-dose Lopinavir/Ritonavir, Double-dose Lopinavir/Ritonavir, Raltegravir)
Terminated
- HIV Infection
- Tuberculosis
- Standard-dose Lopinavir/Ritonavir
- +8 more
-
Porto Alegre, RS, Brazil
- +8 more
Feb 7, 2018
Infection, Human Immunodeficiency Virus Trial in Austin (BMS-663068, Rifabutin, Ritonavir)
Completed
- Infection, Human Immunodeficiency Virus
- BMS-663068
- +2 more
-
Austin, TexasGSK Investigational Site
Sep 21, 2017
Nontuberculous Mycobacterial Infections Trial in Tyler (Rifabutin)
Completed
- Nontuberculous Mycobacterial Infections
- Rifabutin
-
Tyler, TexasThe University of Texas Health Science Center at Tyler
May 19, 2017